Kaya Holdings (Kaya Holdings) FCF Margin % : -558.82% (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Kaya Holdings FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Kaya Holdings's Free Cash Flow for the three months ended in Dec. 2023 was $-0.19 Mil. Kaya Holdings's Revenue for the three months ended in Dec. 2023 was $0.03 Mil. Therefore, Kaya Holdings's FCF Margin % for the quarter that ended in Dec. 2023 was -558.82%.

As of today, Kaya Holdings's current FCF Yield % is -134.66%.

The historical rank and industry rank for Kaya Holdings's FCF Margin % or its related term are showing as below:

KAYS' s FCF Margin % Range Over the Past 10 Years
Min: -1180 Med: -134.23 Max: -31.26
Current: -533.16

During the past 11 years, the highest FCF Margin % of Kaya Holdings was -31.26%. The lowest was -1180.00%. And the median was -134.23%.

KAYS's FCF Margin % is ranked worse than
95.03% of 1026 companies
in the Drug Manufacturers industry
Industry Median: -0.675 vs KAYS: -533.16

Kaya Holdings FCF Margin % Historical Data

The historical data trend for Kaya Holdings's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kaya Holdings FCF Margin % Chart

Kaya Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-78.40

-31.26

-118.54

-134.16

-533.67

Kaya Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-182.95	-647.92	-680.00	-288.14	-558.82

Competitive Comparison of Kaya Holdings's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Kaya Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kaya Holdings's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kaya Holdings's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Kaya Holdings's FCF Margin % falls into.

Kaya Holdings FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Kaya Holdings's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-1.046	/	0.196
	=	-533.67 %

Kaya Holdings's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-0.19	/	0.034
	=	-558.82 %

Kaya Holdings FCF Margin % Related Terms

Thank you for viewing the detailed overview of Kaya Holdings's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Kaya Holdings (Kaya Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kaya Holdings Inc (OTCPK:KAYS) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

915 Middle River Drive, Suite 316, Fort Lauderdale, FL, USA, 33304

Website

https://www.kayaholdings.com

Kaya Holdings Inc is a holding company. It pursues medical and recreational licenses for the growing, processing, and sale of marijuana in jurisdictions through its subsidiaries. The company owns and operates brands that produce, distribute, and sell premium cannabis products including flowers, concentrates, and cannabis-infused baked goods and candies. It mainly operates a vertically integrated seed-to-sale legal marijuana enterprise and its operations include medical marijuana dispensaries, medical marijuana grow-operations, the manufacturing of proprietary cannabis products, and research and development of medical-grade cannabis strains and extracts for pain relief and treatment of serious illnesses. The company operates the Kaya Shack brand of medical marijuana dispensaries.